stopped testing of four of its pcr-based gene mutation assays

Rosetta Genomics

14/10/2016 21:55

Oct 14 (Reuters) - Rosetta Genomics Ltd  ROSG.O  
    * Rosetta Genomics Ltd - co has discontinued testing using 
four of its pcr-based gene mutation assays run out of its lake 
forest, california facility 
    * Rosetta Genomics - instead, co is exploring alternative 
paths to re-establish testing for these gene mutations, and 
revalidating these assays 
    * Rosetta Genomics - during the interim period co is 
satisfying its customer needs for this testing through third 
party laboratories 
 
Source text:  ID:nEOL5kKKVJ  
Further company coverage:  ROSG.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))